Phosphorylation of Histone H4T80 Triggers DNA Damage Checkpoint Recovery.
Robson, Samuel C
MetadataShow full item record
Millan-Zambrano, G., Santos-Rosa, H., Puddu, F., Robson, S. C., Jackson, S., & Kouzarides, T. (2018). Phosphorylation of Histone H4T80 Triggers DNA Damage Checkpoint Recovery.. Molecular cell, 72 (4), 625-635.e4. https://doi.org/10.1016/j.molcel.2018.09.023
In response to genotoxic stress, cells activate a signalling cascade known as the DNA damage checkpoint (DDC) that leads to a temporary cell cycle arrest and activation of DNA repair mechanisms. Because persistent DDC activation compromises cell viability, this process must be tightly regulated. However, despite its importance the mechanisms regulating DDC recovery are not completely understood. Here, we identify a DNA damage regulated histone modification in Saccharomyces cerevisiae, phosphorylation of H4 threonine 80 (H4T80ph), and show that it triggers checkpoint inactivation. H4T80ph is critical for cell survival to DNA damage, and its absence causes impaired DDC recovery and persistent cell cycle arrest. We show that in response to genotoxic stress, p21-activated kinase Cla4 phosphorylates H4T80 to recruit Rtt107 to sites of DNA damage. Rtt107 displaces the checkpoint adaptor Rad9, thereby interrupting the checkpoint-signalling cascade. Collectively, our results indicate that H4T80ph regulates DDC recovery.
Saccharomyces cerevisiae, DNA Damage, Protein-Serine-Threonine Kinases, Intracellular Signaling Peptides and Proteins, Cell Cycle Proteins, Saccharomyces cerevisiae Proteins, Nuclear Proteins, Histones, Signal Transduction, DNA Repair, Protein Binding, Phosphorylation, Cell Cycle Checkpoints, Checkpoint Kinase 2
The Kouzarides laboratory is supported by Cancer Research UK (grant reference RG17001). The Jackson laboratory is supported by Cancer Research UK (grant reference C6/A18796) and Wellcome Trust (Investigator Award 206388/Z/17/Z). Both laboratories benefit from core support from the Wellcome Trust (Core Grant reference WT203144) and Cancer Research UK (grant reference C6946/A24843). G.M.-Z. was funded by an EMBO long-term fellowship (ALTF907- 2014).
Cancer Research UK (17001)
Cancer Research UK (18796)
Wellcome Trust (206388/Z/17/Z)
Cancer Research UK (C6946/A24843)
Wellcome Trust (203144/Z/16/Z)
External DOI: https://doi.org/10.1016/j.molcel.2018.09.023
This record's URL: https://www.repository.cam.ac.uk/handle/1810/286255
Attribution 4.0 International
Licence URL: https://creativecommons.org/licenses/by/4.0/